Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 1997

View Archived Issues

New insights into glaucoma and implications for drug therapy

Rutaecarpine, a vasorelaxant component of an herbal drug

New treatment reported for diaper dermatitis

Englitazone mechanism of antidiabetic activity studied in vitro

Mechanism of topical absorption of antiandrogen drug investigated

Maxamine enters phase III for malignant melanoma

Interim U.S. phase III results reported for Gliatech's ADCON-L

ArQule and Wyeth-Ayerst enter into drug discovery collaboration

HIV protease inhibitor enters phase III pediatric trial

NeoTherapeutics begins U.S. clinical trials of AIT-082

Teva receives FDA approval for generic estazolam

The Population Council licenses two hormone replacement products to Sano

Update on CellPro's CEPRATE SC Stem Cell Concentration System

Allergan prepares compounds with retinoid-like activity

MMP inhibitors from Warner-Lambert

Celltech discloses potent and selective inhibitors of protein kinases

MS&D reveals agents for migraine

Chiroscience claims MMP/TNF inhibitors

Dual H1/NK1 antagonists from Hoechst Marion Roussel

Univ. of Pennsylvania team discovers new Alzheimer's lesion

ICRF-187 for preventing anthracycline cardiotoxicity in children

Immunomedics issued U.S. patent for cardiovascular diagnostic

Mibefradil more effective than extended-release diltiazem in hypertension

Efficacy of botulinum toxin type C in humans

Vitamin B12 depletion reported to induce apoptosis

Potent and selective M2 receptor antagonist discovered by Yamanouchi

Geron's telomerase technology covered under U.S. patent

Dainippon presents promising antisecretory agent

Bigmar submits ANDA for leucovorin

NIH researchers identify gene associated with Niemann-Pick type C

Eclipse submits PMA for Transmyocardial Revascularization procedure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...